Decoy Therapeutics Inc. (Investor Relations)Jun 5, 2026IPO filing
On June 5, 2026, Decoy Therapeutics requested that its Form S-3 registration statement (initially filed Aug. 15, 2025; File No. 333-289646) be withdrawn under Rule 477, stating it has determined not to proceed with the proposed offering at this time.